Expiration date: 10/2025

Description

Suspension of light orange or orange color with a characteristic smell.

Pharmacotherapeutic group: analgesic agent (NSAIDs+ analgesic non-narcotic agent).

 ATX code: M01AE51

Pharmacological properties

Combined preparation.

It has analgesic, anti-inflammatory and antipyretic effect. The mechanism of action of ibuprofen and paracetamol is due to inhibition of prostaglandin biosynthesis-pain and inflammation mediators.

Indications for use

Broffice Plus used in children 2 years of age.

As a antipyretic agent for:

• acute respiratory diseases;
  
• flu;
  
• children's infectious diseases;
  
• post-vaccination reactions and other infectious and inflammatory diseases, accompanied by an increase in body temperature.
  

As a pain reliever of mild to moderate intensity in:

• headache and toothache;
  
• migraines;
  
• neuralgias;
  
• pain in the ears and throat;
  
• muscle pain;
  
• pain with injuries, sprains, burns and other types of pain.
  

Contraindications

The drug should not be used when:

• hypersensitivity to ibuprofen and / or paracetamol;
  
• erosive and ulcerative diseases of the gastrointestinal tract (including gastric and duodenal ulcer, Crohn's disease, ulcerative colitis) or ulcerative bleeding in the active phase or in the anamnesis (two or more confirmed episodes of peptic ulcer disease or ulcerative bleeding);
  
• bleeding or perforation of ulcers of the gastrointestinal tract in history, provoked by the use of NSAIDs;
  
• complete or incomplete combination of bronchial asthma, recurrent polyposis of the nose and paranasal sinuses, and intolerance to acetylsalicylic acid or other NSAIDs;
  
• violation of blood clotting (including hemophilia, hemorrhagic diathesis);
  
• severe renal failure (creatinine clearance less than 30 ml / min);
  
• cerebrovascular or other bleeding;
  
• severe liver and kidney disorders;
  
• severe liver failure or active liver disease;
  
• decompensated cardiovascular failure;
  
• state after coronary artery bypass grafting;
  
• confirmed hyperkalemia;
  
• pregnancy III trimester;
  
• during breast-feeding;
  
• children under 2 years.